Abstract
In this study, we used three-dimensional human engineered cardiac tissue technology to directly show that phospholamban (PLN) R14del mutation impairs cardiac contractility and to demonstrate restoration of contractile properties with targeted genetic correction of this inheritable form of dilated cardiomyopathy.
| Original language | English |
|---|---|
| Pages (from-to) | 3282-3284 |
| Number of pages | 3 |
| Journal | European heart journal |
| Volume | 37 |
| Issue number | 43 |
| DOIs | |
| Publication status | Published - 1 Nov 2016 |
| Externally published | Yes |
Keywords
- Dilated cardiomyopathy
- Engineered heart tissue
- Gene editing
- Induced pluripotent stem cells
- Phospholamban
Fingerprint
Dive into the research topics of 'Genomic correction of familial cardiomyopathy in human engineered cardiac tissues'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver